Study guide
1.1 Maternal-Perinatal History & Antepartum Risk Factors
Neonatal Intensive Care Nursing RNC-NIC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: General Assessment & History
1.1 Maternal-Perinatal History & Antepartum Risk Factors 1.2 Physical Assessment of the Neonate 1.3 Gestational Age & Neurobehavioral Assessment
2 Chapter 2: Resuscitation, Stabilization & Thermoregulation
2.1 Neonatal Resuscitation Program (NRP) Guidelines 2.2 Post-Resuscitation Stabilization & Transport 2.3 Thermoregulation & Neutral Thermal Environment
3 Chapter 3: Fluid, Electrolyte & Glucose Management
3.1 Fluid Balance & Electrolyte Homeostasis 3.2 Glucose Homeostasis: Hypoglycemia & Hyperglycemia 3.3 Neonatal Parenteral & Enteral Nutrition
4 Chapter 4: Oxygenation, Ventilation & Acid-Base Balance
4.1 Oxygen Therapy & Non-Invasive Respiratory Support 4.2 Mechanical Ventilation Strategies 4.3 Blood Gas Analysis & Acid-Base Balance
5 Chapter 5: Cardiovascular Disorders
5.1 Congenital Heart Defects (Acyanotic vs. Cyanotic) 5.2 Patent Ductus Arteriosus (PDA) & Persistent Pulmonary Hypertension (PPHN) 5.3 Congestive Heart Failure & Shock
6 Chapter 6: Respiratory Disorders
6.1 Transient Tachypnea of the Newborn (TTN) & Respiratory Distress Syndrome (RDS) 6.2 Meconium Aspiration Syndrome (MAS) & Air Leak Syndromes 6.3 Bronchopulmonary Dysplasia (BPD) & Apnea of Prematurity
7 Chapter 7: Gastrointestinal & Neurological Disorders
7.1 Necrotizing Enterocolitis (NEC) & Feeding Intolerance 7.2 Hypoxic-Ischemic Encephalopathy (HIE) & Therapeutic Hypothermia 7.3 Neonatal Seizures & Intraventricular Hemorrhage (IVH)
8 Chapter 8: Hematologic, Metabolic & Infectious Disorders
8.1 Neonatal Hyperbilirubinemia & Jaundice Management 8.2 Neonatal Sepsis & Infectious Pathogens 8.3 Neonatal Abstinence Syndrome (NAS) & Toxicology
9 Chapter 9: Psychosocial Support & Professional Issues
9.1 Family-Centered Care & Developmental Care 9.2 Ethical & Legal Aspects in Neonatal Intensive Care 9.3 Quality Improvement, Safety & Patient Outcomes
1.1 Maternal-Perinatal History & Antepartum Risk Factors
Key Takeaways Explain This Topic AI
Pre-gestational diabetes increases the risk of congenital anomalies like caudal regression syndrome and transposition of the great arteries due to first-trimester hyperglycemia, whereas gestational diabetes does not because GDM occurs after organogenesis is complete.
Magnesium sulfate crosses the placenta and can cause neonatal hypotonia, lethargy, and respiratory depression, which is managed with supportive ventilation and, if necessary, calcium gluconate as the antidote.
Severe perinatal acidemia indicating intrapartum asphyxia is defined by an umbilical artery pH of less than 7.00 and a base deficit of 12 mmol/L or greater, which is strongly associated with subsequent hypoxic-ischemic encephalopathy.
Vertical transmission of Hepatitis B from an HBsAg-positive mother is prevented by administering both the Hepatitis B vaccine and Hepatitis B Immune Globulin (HBIG) within 12 hours of birth.
Last updated: July 2026
Maternal-Perinatal History & Antepartum Risk Factors
The neonatal period is inextricably linked to maternal health, placental function, and intrapartum events. Recognizing how antepartum risk factors translate into neonatal pathophysiology is a cornerstone of advanced neonatal intensive care nursing.
- Maternal Chronic Illnesses & Neonatal Consequences
- Maternal Diabetes: Pre-gestational vs. Gestational
Maternal diabetes mellitus (DM) alters the fetal metabolic milieu, but the timing of maternal hyperglycemia dictates the specific neonatal risks.
Pre-gestational Diabetes (Type 1 or Type 2): Poor glycemic control during embryogenesis (first 8 weeks of gestation) is highly teratogenic. The risk of congenital anomalies is increased 3- to 4-fold.
Cardiovascular Anomalies: Transposition of the great arteries (TGA), ventricular septal defects (VSD), and transient hypertrophic cardiomyopathy (HCM). HCM is driven by fetal hyperinsulinemia causing glycogen deposition in the ventricular septum, leading to left ventricular outflow tract (LVOT) obstruction.
Neurological/Musculoskeletal: Neural tube defects, sacral agenesis (caudal regression syndrome), which is highly specific to diabetic embryopathy.
Gestational Diabetes Mellitus (GDM): GDM develops later in pregnancy (typically after 24 weeks) after organogenesis is complete. Therefore, GDM does not increase the risk of congenital anomalies. However, both pre-gestational and gestational diabetes cause fetal hyperinsulinemia.
Pathophysiology of Fetal Hyperinsulinemia
Glucose crosses the placenta via facilitated diffusion, but maternal insulin does not. Fetal hyperglycemia stimulates the fetal pancreas to secrete excess insulin. Insulin acts as a primary fetal growth hormone, leading to macrosomia (birth weight >90th percentile or >4000g). Post-birth, when the maternal glucose supply is abruptly severed, persistent high levels of circulating fetal insulin cause rapid intracellular glucose shift, resulting in severe neonatal hypoglycemia. This typically peaks between 1 and 2 hours of life. Furthermore, fetal hyperinsulinemia inhibits surfactant production by interfering with phosphatidylglycerol (PG) synthesis, increasing the risk of respiratory distress syndrome (RDS) even in term infants.
Maternal Hypertension and Preeclampsia
Preeclampsia is characterized by maternal endothelial dysfunction, vasospasm, and abnormal placentation, leading to chronic uteroplacental insufficiency.
Fetal Effects: Chronic hypoxia leads to fetal growth restriction (FGR) and intrauterine growth restriction (IUGR). The fetus compensates for hypoxia by increasing erythropoietin production, resulting in neonatal polycythemia (venous hematocrit >65%). This increases blood viscosity, putting the infant at risk for microvascular thrombosis, necrotizing enterocolitis (NEC), and hyperbilirubinemia.
Hematologic Effects: Neonates born to preeclamptic mothers often exhibit transient neutropenia and thrombocytopenia due to placental-derived inhibitors of megakaryopoiesis and granulopoiesis.
Magnesium Sulfate Exposure: Magnesium sulfate administered to the mother for neuroprotection or seizure prophylaxis crosses the placenta. High neonatal magnesium levels cause neuromuscular blockade, manifesting as hypotonia, poor suck, lethargy, and respiratory depression. The immediate antidote for severe magnesium-induced depression in the neonate is calcium gluconate.
Maternal Autoimmune & Endocrine Disorders
Systemic Lupus Erythematosus (SLE): Maternal anti-SSA (Ro) and anti-SSB (La) antibodies cross the placenta. They bind to fetal cardiac conduction tissue, causing inflammation and subsequent fibrosis of the atrioventricular (AV) node. This leads to congenital third-degree heart block , which is permanent and often requires postnatal pacemaker placement. Neonatal lupus also causes transient discoid skin lesions, thrombocytopenia, and leukopenia, which resolve as maternal IgG clears by 6 months of age.
Thyroid Dysfunction: Maternal Graves' disease involves thyroid-stimulating immunoglobulins (TSI) that cross the placenta. This can cause neonatal thyrotoxicosis , characterized by tachycardia, goiter, irritability, exophthalmos, poor weight gain despite high intake, and craniosynostosis.
Maternal & Perinatal Infections (TORCH and Beyond)
Congenital and perinatal infections represent significant sources of neonatal morbidity. The timing and route of transmission guide clinical presentation.
Pathogen Transmission Route Key Neonatal Clinical Features Diagnosis & Management
Toxoplasmosis Transplacental Chorioretinitis, obstructive hydrocephalus, diffuse intracranial calcifications Pyrimethamine, sulfadiazine, and folinic acid for 1 year
Syphilis Transplacental Rhinorrhea ("snuffles"), copper-colored maculopapular rash on palms/soles, osteochondritis, periostitis RPR/VDRL; Penicillin G (IV or IM depending on CNS involvement)
Rubella Transplacental Cataracts, sensorineural hearing loss, patent ductus arteriosus (PDA), "blueberry muffin" spots Supportive care; strict isolation (shed virus in urine for up to 1 year)
CMV Transplacental (most common) Microcephaly, periventricular calcifications, sensorineural hearing loss, petechial rash Urine/saliva PCR within first 21 days; IV Ganciclovir or oral Valganciclovir
HSV Intrapartum (ascending/contact) SEM (Skin, Eyes, Mouth) vesicles; CNS disease (seizures, lethargy); Disseminated (liver failure, DIC) Surface/CSF PCR; IV Acyclovir (high dose: 20 mg/kg every 8 hours)
GBS Intrapartum Early-onset sepsis (pneumonia, meningitis) within 72 hours of birth Maternal screening 36 0/7–37 6/7 weeks; Intrapartum Penicillin G
Substance Exposure & Neonatal Adaptation
Opioids: Prenatal exposure to heroin, methadone, or buprenorphine causes Neonatal Opioid Withdrawal Syndrome (NOWS). Withdrawal symptoms involve CNS irritability (high-pitched cry, tremors, hypertonicity, seizures), gastrointestinal dysfunction (diarrhea, vomiting, poor feeding), and autonomic instability (sneezing, yawning, tachypnea, sweating). Assessment is performed using the Finnegan Scoring System or Eat, Sleep, Console (ESC) model. First-line management is non-pharmacological (swaddling, quiet environment, low light, skin-to-skin). Pharmacological therapy (morphine or methadone) is indicated if supportive measures fail.
Cocaine: Cocaine is a potent vasoconstrictor. It does not cause a classic withdrawal syndrome but increases the risk of placental abruption, uterine hypoxia, and FGR. Exposed neonates exhibit neurobehavioral abnormalities, including hypertonia, irritability, and poor state regulation.
SSRIs: Late third-trimester exposure can lead to Neonatal Behavioral Adaptation Syndrome (irritability, jitteriness, mild respiratory distress). It is also associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN).
- Intrapartum Factors & Asphyxia Assessment
- Rupture of Membranes & Chorioamnionitis
Prolonged rupture of membranes (PROM) is defined as rupture >18 hours before delivery. It is a major risk factor for ascending bacterial infection leading to chorioamnionitis (intra-amniotic infection). Maternal indicators include fever (>38.0°C), maternal tachycardia (>100 bpm), fetal tachycardia (>160 bpm), uterine tenderness, and foul-smelling amniotic fluid. Neonates exposed to chorioamnionitis require evaluation (blood culture, CBC) and empiric antibiotic therapy (Ampicillin and Gentamicin) immediately after birth.
Fetal Heart Rate (FHR) Monitoring & Cord Gases
FHR patterns indicate fetal oxygenation status:
Category I (Normal): Predictive of normal acid-base status. Requires no specific intervention.
Category II (Indeterminate): Not predictive of abnormal acid-base status but requires evaluation and continued monitoring.
Category III (Abnormal): Associated with abnormal fetal acid-base status. Characterized by absent baseline variability and recurrent late decelerations, recurrent variable decelerations, bradycardia, or a sinusoidal pattern. Preparation for neonatal resuscitation must be initiated.
Umbilical Cord Blood Gas Analysis: Obtained immediately after delivery. Arterial cord gas reflects fetal tissue perfusion. Normal arterial pH is 7.20 to 7.25. Perinatal asphyxia is defined as an arterial pH < 7.00 with a base deficit ≥ 12 mmol/L.
The APGAR Score
The APGAR score evaluates transition at 1 and 5 minutes. If the 5-minute score is < 7, the assessment must be repeated every 5 minutes up to 20 minutes.
- Score 0 Points 1 Point 2 Points
- Appearance (Color) Blue, pale Acrocyanosis (body pink, extremities blue) Completely pink
- Pulse (Heart Rate) Absent < 100 bpm ≥ 100 bpm
- Grimace (Reflex) No response Grimace Cry, cough, or sneeze
- Activity (Muscle Tone) Limp Some flexion of extremities Active motion
- Respiration Absent Slow, irregular; weak cry Good, crying
Clinical Note: The APGAR score is not used to guide active resuscitation. Resuscitative efforts must be initiated immediately based on heart rate, respirations, and muscle tone, without waiting for the 1-minute APGAR score.
Clinical Scenarios & Exam Traps
[WARNING] Exam Trap: On the RNC-NIC exam, candidates are often tripped up by the distinction between maternal and fetal insulin. Remember: Insulin does not cross the placenta. Maternal hyperglycemia causes fetal hyperglycemia, which leads to fetal pancreatic hyperplasia and fetal hyperinsulinemia. In contrast, glucose does cross the placenta via facilitated diffusion.